Dae Gon Ha
Stock Analyst at Stifel
(2.61)
# 2,301
Out of 5,081 analysts
46
Total ratings
36.84%
Success rate
8.23%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Dae Gon Ha
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MIRM Mirum Pharmaceuticals | Reinstates: Buy | $89 | $70.99 | +25.37% | 4 | Aug 11, 2025 | |
| ABEO Abeona Therapeutics | Maintains: Buy | $21 → $20 | $4.73 | +322.83% | 2 | May 16, 2025 | |
| EDIT Editas Medicine | Downgrades: Hold | $11 → $3 | $2.37 | +26.85% | 4 | Dec 13, 2024 | |
| SLNO Soleno Therapeutics | Maintains: Buy | $59 → $74 | $50.72 | +45.90% | 2 | Oct 1, 2024 | |
| FULC Fulcrum Therapeutics | Downgrades: Hold | $22 → $3 | $9.06 | -66.89% | 4 | Sep 12, 2024 | |
| NTLA Intellia Therapeutics | Maintains: Buy | $80 → $64 | $9.06 | +606.40% | 2 | Sep 11, 2024 | |
| KRYS Krystal Biotech | Maintains: Buy | $204 → $220 | $217.73 | +1.04% | 4 | Sep 11, 2024 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Buy | $124 → $127 | $36.45 | +248.42% | 2 | May 31, 2024 | |
| RCKT Rocket Pharmaceuticals | Reiterates: Buy | $48 | $3.34 | +1,337.13% | 4 | Sep 13, 2023 | |
| PRME Prime Medicine | Initiates: Buy | $18 | $3.61 | +398.61% | 1 | Apr 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $7 | $0.87 | +703.21% | 1 | Mar 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $25 | $104.63 | -76.11% | 4 | Jun 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $12 → $16 | $9.78 | +63.60% | 3 | Nov 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $285 | $15.71 | +1,714.17% | 1 | Sep 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $2.01 | +895.02% | 1 | May 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $10.67 | - | 2 | Sep 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $21.25 | - | 1 | Jun 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $7.85 | - | 1 | Jun 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $1.02 | +1,076.47% | 1 | Jun 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $600 → $490 | $12.99 | +3,672.13% | 2 | Oct 23, 2017 |
Mirum Pharmaceuticals
Aug 11, 2025
Reinstates: Buy
Price Target: $89
Current: $70.99
Upside: +25.37%
Abeona Therapeutics
May 16, 2025
Maintains: Buy
Price Target: $21 → $20
Current: $4.73
Upside: +322.83%
Editas Medicine
Dec 13, 2024
Downgrades: Hold
Price Target: $11 → $3
Current: $2.37
Upside: +26.85%
Soleno Therapeutics
Oct 1, 2024
Maintains: Buy
Price Target: $59 → $74
Current: $50.72
Upside: +45.90%
Fulcrum Therapeutics
Sep 12, 2024
Downgrades: Hold
Price Target: $22 → $3
Current: $9.06
Upside: -66.89%
Intellia Therapeutics
Sep 11, 2024
Maintains: Buy
Price Target: $80 → $64
Current: $9.06
Upside: +606.40%
Krystal Biotech
Sep 11, 2024
Maintains: Buy
Price Target: $204 → $220
Current: $217.73
Upside: +1.04%
Ultragenyx Pharmaceutical
May 31, 2024
Maintains: Buy
Price Target: $124 → $127
Current: $36.45
Upside: +248.42%
Rocket Pharmaceuticals
Sep 13, 2023
Reiterates: Buy
Price Target: $48
Current: $3.34
Upside: +1,337.13%
Prime Medicine
Apr 18, 2023
Initiates: Buy
Price Target: $18
Current: $3.61
Upside: +398.61%
Mar 24, 2023
Maintains: Buy
Price Target: $12 → $7
Current: $0.87
Upside: +703.21%
Jun 17, 2022
Maintains: Buy
Price Target: $23 → $25
Current: $104.63
Upside: -76.11%
Nov 15, 2021
Upgrades: Buy
Price Target: $12 → $16
Current: $9.78
Upside: +63.60%
Sep 7, 2021
Initiates: Buy
Price Target: $285
Current: $15.71
Upside: +1,714.17%
May 3, 2021
Initiates: Buy
Price Target: $20
Current: $2.01
Upside: +895.02%
Sep 8, 2020
Downgrades: Neutral
Price Target: n/a
Current: $10.67
Upside: -
Jun 17, 2020
Initiates: Neutral
Price Target: n/a
Current: $21.25
Upside: -
Jun 17, 2020
Initiates: Neutral
Price Target: n/a
Current: $7.85
Upside: -
Jun 17, 2020
Initiates: Buy
Price Target: $12
Current: $1.02
Upside: +1,076.47%
Oct 23, 2017
Maintains: Outperform
Price Target: $600 → $490
Current: $12.99
Upside: +3,672.13%